Karin Björck

Statistics

Publications

Citations

217

H-Index

Active since

2006

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (Sweden)

University of North Carolina at Chapel Hill

Karin Björck is an author at AstraZeneca (United States) specializing in gastrointestinal pharmacotherapy, pharmacotherapy, and pharmacologic therapy for gerd.

Publications per year

2006–2013

Publications

A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial

Guy E. Boeckxstaens, Hanneke Beaumont, Jan Gunnar Hatlebakk et al. · Gut · 2011 · 81 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial

Nicholas J. Shaheen, Hans Denison, Karin Björck et al. · Gut · 2012 · 58 citations

Medicine, Pharmacology, Pharmacotherapy +14

Analysis of Chromosome 5q31–32 and Psoriasis: Confirmation of a Susceptibility Locus but no Association with SNPs within SLC22A4 and SLC22A5

Camilla Friberg, Karin Björck, Staffan Nilsson et al. · Journal of Investigative Dermatology · 2006 · 27 citations

Life Sciences, Genetics, Molecular Genetics +13

Genome‐wide linkage scan for breast cancer susceptibility loci in Swedish hereditary non‐<i>BRCA1/2</i> families: Suggestive linkage to 10q23.32‐q25.3

Annika Bergman, Per Karlsson, Jonna Berggren et al. · Genes Chromosomes and Cancer · 2006 · 23 citations

Life Sciences, Genetics, Molecular Genetics +17

Validation of the Reflux Symptom Questionnaire Electronic Diary in Partial Responders to Proton Pump Inhibitor Therapy

Nimish Vakil, Karin Björck, Hans Denison et al. · Clinical and Translational Gastroenterology · 2012 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 6